Contact Us
Drug Search Results
More Filters [+]

Mequitazine

Alternative Names: mequitazine
Latest Update: 2022-08-29
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: H1 Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Algeria | Brazil | Chile | Dominican Republic | Egypt | France | Ireland | Italy | Korea | Lebanon | Morocco | New Zealand | Peru | Portugal | Russia | Spain | Taiwan | Tunisia | United Arab Emirates | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Pierre Fabre Laboratories
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Mequitazine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Rhinitis, Allergic, Seasonal|Chikungunya Fever

Phase 2: Overactive Bladder|Asthma|Rhinitis, Allergic, Seasonal

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
2013-002517-35

P2

Completed

Asthma

2014-04-22

2008-001860-36

P3

Completed

Rhinitis, Allergic, Seasonal

2013-05-29

2010-024271-10

P2

Terminated

Overactive Bladder

2011-09-14

2006-006165-17

P3

Active, not recruiting

Chikungunya Fever

2007-12-20

Recent News Events

Date

Type

Title

08/29/2022

PubMed

 Experimental verification and validation of immune biomarkers based on chromatin regulators in ischemic stroke.

08/01/2021

PubMed

 Chiral separation and molecular simulation study of six antihistamine agents on a coated cellulose tri-(3,5-dimethylphenycarbamate) column (Chiralcel OD-RH) and its recognition mechanisms.

04/01/2020

PubMed

 Second-generation antihistamines: a study of poisoning in children.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions